New York Genome Center - A Nonprofit Academic Research Institution

Two scientists looking at a close up of a bacteria slide on a monitor

The New York Genome Center (NYGC) is an independent, nonprofit academic research institute launched in 2011 that serves as a multi-institutional hub for genomic research. Leveraging our strengths in whole-genome sequencing and genomic analysis, our mission is the advancement of genomic science and its application to drive novel biomedical discoveries. NYGC’s areas of focus include the development of computational and experimental genomic methods and disease-focused research to better understand the genetic basis of cancer, neurodegenerative disease, and neuropsychiatric disease. In 2020, the NYGC also has directed its expertise to COVID-19 research.We are committed to prioritizing diversity, equity, and inclusion, which is fundamental to promoting greater collaboration, innovation, and discovery. Learn more about NYGC’s Commitment to Diversity, Equity, and Inclusion.

Read The New York Times Magazine feature showcasing NYGC’s collaborative COVID-19 research as well as our partnership with Weill Cornell Medicine and NewYork-Presbyterian Hospital to conduct clinical whole-genome sequencing for thousands of patients.

News

All News

Two New York Genome Center Research Teams Selected as Grant Recipients Under NIH Common Fund SMaHT Network

CRISPR and Single-cell Sequencing Pinpoint Causal Genetic Variants for Traits and Diseases

NYGC Affiliate Columbia University Announces New Center for Precision Psychiatry & Mental Health

NYGC’s Internship Program Featured in Partnership for NYC’s Portfolio Company Spotlight

NYGC Awarded BD2 Grant, Expanding Diversity in Sequencing Dataset for the Study of Bipolar Disorder

New Findings Better Identify Early Detection Strategy for Stomach and Esophagus Cancers

01 / 02

Publications & Pre-Prints

All Publications

Human Genomics. 2021 July 13.

Coding and noncoding variants in EBF3 are involved in HADDS and simplex autism.

Evin M Padhi, Tristan J Hayeck, Zhang Cheng, Sumantra Chatterjee, Brandon J Mannion, Marta Byrska-Bishop, Marjolaine Willems, Lucile Pinson, Sylvia Redon, Caroline Benech, Kevin Uguen, Séverine Audebert-Bellanger, Cédric Le Marechal, Claude Férec, Stephanie Efthymiou, Fatima Rahman, Shazia Maqbool, Reza Maroofian, Henry Houlden, Rajeeva Musunuri, Giuseppe Narzisi, Avinash Abhyankar, Riana D Hunter, Jennifer Akiyama, Lauren E Fries, Jeffrey K Ng, Elvisa Mehinovic, Nick Stong, Andrew S Allen, Diane E Dickel, Raphael A Bernier, David U Gorkin, Len A Pennacchio, Michael C Zody, Tychele N Turner

medRxiv. 2021 July 5.

Post-vaccination SARS-COV-2 among healthcare workers in New Jersey: a genomic epidemiological study.

Barun Mathema, Liang Chen, Kar Fai Chow, Yanan Zhao, Michael C Zody, Jose R Mediavilla, Marcus H Cunningham, Kaelea Composto, Annie Lee, Dayna M Oschwald, Soren Germer, Samantha Fennessey, Kishan Patel, David Wilson, Ann Cassell, Lauren Pascual, Andrew Ip, André Corvelo, Sophia Dar, Yael Kramer, Tom Maniatis, David S Perlin, Barry N Kreiswirth

Seminars in Cancer Biology. 2021 June 25.

Clinical utility of whole-genome sequencing in precision oncology.

Richard Rosenquist, Edwin Cuppen, Reinhard Buettner, Carlos Caldas, Helene Dreau, Olivier Elemento, Geert Frederix, Sean Grimmond, Torsten Haferlach, Vaidehi Jobanputra, Manja Meggendorfer, Charles G Mullighan, Sarah Wordsworth, Anna Schuh

Faculty Labs

NYGC Labs